Screening for glycosylation changes on recombinant human IgG using lectin methods

被引:8
作者
Fotinopoulou, A
Meyers, T
Varley, P
Turner, G [1 ]
机构
[1] Sch Med, Dept Clin Biochem, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Cambridge Antibody Technol, Melbourn SG8 6JJ, Cambs, England
关键词
carbohydrate; ELISA; glycan; surface plasmon resonance; therapeutic;
D O I
10.1042/BA20020023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two lectin-binding methods were investigated as possible ways of monitoring the glycosylation of human monoclonal antibodies during their development and production. Carbohydrate composition was assessed in various preparations that were produced in different host cell types, cell sublines or batches of the same cells. The lectin binding was measured with ELISA and surface plasmon resonance (SPR). For comparative purposes, the monosaccharide content of many of the preparations was also measured by high-pressure anion exchange chromatography (HPAEC)/pulsed amperometric detection (PAD). Both lectin methods detected modifications in glycosylation when antibodies were produced in different ways; SPR was more sensitive than ELISA for some lectins and vice versa. Generally, the lectin results agreed with those obtained by the monosaccharide analysis; however, the former were much better for assessing N-acetylneuraminic acid changes. The latter were impossible to assess by HPAEC/PAD because of their low levels. The lectin-based methods also had the advantages that they were quicker to perform and required less expertise and could quickly identify structures that monosaccharide analysis might miss. It is suggested that, in the development of therapeutic proteins, monosaccharide analysis and/or oligosaccharide profiling is initially performed but later routine batches of the glycoprotein are screened with a lectin method. Of the two lectin methods used, SPR is much quicker when performing a screen, whereas Ell is particularly useful for comparing a particular carbohydrate feature on different samples of the same glycoprotein.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 17 条
[1]   Advances in animal cell recombinant protein production: GS-NS0 expression system [J].
Barnes L.M. ;
Bentley C.M. ;
Dickson A.J. .
Barnes, L.M., 2000, Springer Netherlands (32) :109-123
[2]  
Durand G, 2000, CLIN CHEM, V46, P795
[3]   Glycobiology: Toward understanding the function of sugars [J].
Dwek, RA .
CHEMICAL REVIEWS, 1996, 96 (02) :683-720
[4]  
Fotinopoulou A., 2002, PROTEIN PROTOC HDB, P885
[5]   Clinical trials of antibody therapy [J].
Glennie, MJ ;
Johnson, PWM .
IMMUNOLOGY TODAY, 2000, 21 (08) :403-410
[6]  
Goodarzi M.T., 2002, PROTEIN PROTOCOLS HD, P795
[7]   DECREASED BRANCHING, INCREASED FUCOSYLATION AND CHANGED SIALYLATION OF ALPHA-1-PROTEINASE INHIBITOR IN BREAST AND OVARIAN-CANCER [J].
GOODARZI, MT ;
TURNER, GA .
CLINICA CHIMICA ACTA, 1995, 236 (02) :161-171
[8]   CHARACTERIZATION OF GLYCOPROTEIN OLIGOSACCHARIDES USING SURFACE-PLASMON RESONANCE [J].
HUTCHINSON, AM .
ANALYTICAL BIOCHEMISTRY, 1994, 220 (02) :303-307
[9]   Effect of N-linked glycosylation on glycopeptide and glycoprotein structure [J].
Imperiali, B ;
O'Connor, SE .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (06) :643-649
[10]   Getting the glycosylation right: Implications for the biotechnology industry [J].
Jenkins, N ;
Parekh, RB ;
James, DC .
NATURE BIOTECHNOLOGY, 1996, 14 (08) :975-981